Predicting Outcome Of Treatment With An Anti- 4 7 Integrin Antibody

Patent No. EP3237004 (titled "Predicting Outcome Of Treatment With An Anti- 4 7 Integrin Antibody") was filed by Millennium Pharmaceuticals on Dec 23, 2015. The application was issued on May 8, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
POLPHARMA BIOLOGICSFeb 7, 2025SIMMONS & SIMMONS MUNICH

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3237004

MILLENNIUM PHARMACEUTICALS
Application Number
EP15873834A
Filing Date
Dec 23, 2015
Status
Revoked
Aug 15, 2025
Publication Date
May 8, 2024